KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Thermo Fisher Scientific's Income from Continuing Operations fell 146.07% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 576.27%. This contributed to the annual value of $6.4 billion for FY2024, which is 608.58% up from last year.
  • Per Thermo Fisher Scientific's latest filing, its Income from Continuing Operations stood at $1.6 billion for Q3 2025, which was down 146.07% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Income from Continuing Operations registered a high of $2.3 billion during Q2 2021, and its lowest value of $1.3 billion during Q1 2024.
  • For the 5-year period, Thermo Fisher Scientific's Income from Continuing Operations averaged around $1.7 billion, with its median value being $1.6 billion (2024).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 19657.36% in 2021, then tumbled by 4117.91% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Income from Continuing Operations (Quarter) stood at $1.7 billion in 2021, then dropped by 3.32% to $1.6 billion in 2022, then increased by 0.19% to $1.6 billion in 2023, then grew by 11.45% to $1.8 billion in 2024, then dropped by 9.6% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.5 billion during Q1 2025.